PATRICIA KOPPEIS: Open Payments
NPI 1831205566 · FARMINGTON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$325 in 8 payments from 7 companies in 2025. Trend: 2023 $507 · 2024 $382 · 2025 $325
Food & beverage: $325
| Company | Payments | Amount |
|---|---|---|
| Alexion Pharmaceuticals, Inc. | 1 | $79 |
| Teva Pharmaceuticals USA, Inc. | 1 | $73 |
| Novo Nordisk Inc | 1 | $66 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $42 |
| Janssen Pharmaceuticals, Inc | 1 | $25 |
| Sandoz Inc. | 1 | $24 |
| Xeris Pharmaceuticals, Inc. | 1 | $17 |
Products named: AUSTEDO XR, Ozempic, CAPLYTA, SPRAVATO, HYRIMOZ, KEVEYIS.
Industry payments across MO — which companies pay providers there.
